Disc Medicine Statistics
Total Valuation
Disc Medicine has a market cap or net worth of $1.92 billion. The enterprise value is $1.43 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Disc Medicine has 29.76 million shares outstanding. The number of shares has increased by 58.56% in one year.
| Current Share Class | 29.76M |
| Shares Outstanding | 29.76M |
| Shares Change (YoY) | +58.56% |
| Shares Change (QoQ) | +16.71% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 62.76% |
| Float | 16.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.10 |
| P/TBV Ratio | 4.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.36, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.36 |
| Quick Ratio | 19.13 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.03% and return on invested capital (ROIC) is -18.79%.
| Return on Equity (ROE) | -25.03% |
| Return on Assets (ROA) | -17.91% |
| Return on Capital (ROIC) | -18.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.40M |
| Employee Count | 74 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Disc Medicine has paid $211,000 in taxes.
| Income Tax | 211,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.88% in the last 52 weeks. The beta is 3.03, so Disc Medicine's price volatility has been higher than the market average.
| Beta (5Y) | 3.03 |
| 52-Week Price Change | +9.88% |
| 50-Day Moving Average | 58.50 |
| 200-Day Moving Average | 47.06 |
| Relative Strength Index (RSI) | 54.57 |
| Average Volume (20 Days) | 265,000 |
Short Selling Information
The latest short interest is 1.63 million, so 5.47% of the outstanding shares have been sold short.
| Short Interest | 1.63M |
| Short Previous Month | 1.64M |
| Short % of Shares Out | 5.47% |
| Short % of Float | 9.81% |
| Short Ratio (days to cover) | 4.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -124.88M |
| Pretax Income | -90.89M |
| Net Income | -103.48M |
| EBITDA | -124.71M |
| EBIT | -124.88M |
| Earnings Per Share (EPS) | -$3.95 |
Full Income StatementBalance Sheet
The company has $487.36 million in cash and $1.79 million in debt, giving a net cash position of $485.58 million or $16.32 per share.
| Cash & Cash Equivalents | 487.36M |
| Total Debt | 1.79M |
| Net Cash | 485.58M |
| Net Cash Per Share | $16.32 |
| Equity (Book Value) | 467.96M |
| Book Value Per Share | 15.73 |
| Working Capital | 467.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$84.15 million and capital expenditures -$59,000, giving a free cash flow of -$84.21 million.
| Operating Cash Flow | -84.15M |
| Capital Expenditures | -59,000 |
| Free Cash Flow | -84.21M |
| FCF Per Share | -$2.83 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |